Category Archives: Healthcare

Cryolife (CRY) Gets a Buy Rating from Needham

Needham analyst Michael Matson assigned a Buy rating to Cryolife (CRY – Research Report) today and set a price target of $38.00. The company’s shares closed last Monday at $29.50. According to TipRanks.com, Matson is a 5-star analyst with an

Mizuho Securities Thinks Assembly Biosciences’ Stock is Going to Recover

Mizuho Securities analyst Salim Syed maintained a Buy rating on Assembly Biosciences (ASMB – Research Report) today and set a price target of $13.00. The company’s shares closed last Monday at $3.90, close to its 52-week low of $3.84. According

Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Revance Therapeutics (NASDAQ: RVNC) and FibroGen (NASDAQ: FGEN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report), Revance Therapeutics (RVNC – Research Report) and FibroGen (FGEN – Research Report). Cytokinetics (CYTK) Mizuho Securities analyst Salim

H.C. Wainwright Remains a Buy on Antares Pharma (ATRS)

In a report released today, Oren Livnat from H.C. Wainwright maintained a Buy rating on Antares Pharma (ATRS – Research Report), with a price target of $5.00. The company’s shares closed last Friday at $3.83. According to TipRanks.com, Livnat is

Radius Health (RDUS) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao reiterated a Hold rating on Radius Health (RDUS – Research Report) today and set a price target of $25.00. The company’s shares closed last Friday at $20.60. According to TipRanks.com, Tsao is a 5-star analyst

H.C. Wainwright Reaffirms Their Hold Rating on Ziopharm Oncology (ZIOP)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Hold rating on Ziopharm Oncology (ZIOP – Research Report). The company’s shares closed last Friday at $3.20. According to TipRanks.com, Ramakanth is a 5-star analyst with an average